Serum CA 125 levels (upper normal value< 35 U/ml) determined before surgery and 3
months after surgery were evaluated as independent prognostic factors for survival in …

Pre-treatment serum squamous cell carcinoma antigen [SCC] levels are elevated in 28–88%
of patients with squamous cell cervical cancer, and are related to tumour stage, tumour size …

Serum levels of squamous cell carcinoma antigen (SCC), CA 125 and CA 15.3 were
measured in 102 patients with locally advanced cervical cancer undergoing neoadjuvant …

Objective: The purpose of this study was too evaluate preoperative levels of CA 125 in for
the prediction of advanced uterine cancer. Study Design: We conducted a retrospective …

Abstract Between January 1986 and December 1988, 36 patients with primary advanced or
recurrent cervical carcinoma were treated with cytostatic drugs in our department. Treatment …

Serial serum CA-125 levels were measured in fifteen patients with recurrent or advanced
endometrial carcinoma during treatment with chemo-or hormonal therapy. All patients had …

Serum CA125 is elevated in some endometrial cancer patients. The purpose of the present
study was to assess the correlation between the presence of CA125 in endometrial cancer …

Purpose The purpose was to evaluate the prognostic significance of serum tumour markers
and other potential prognostic factors in cervical cancer. Materials and methods Five …

Serum levels of carcinoembryonic antigen (CEA), CA 125 and CA 15–3 were measured in
47 patients with endometrial cancer and 20 with endometrial hyperplasia. Before treatment …

Serum CA 125 levels were normal preoperatively in 123 of 125 (98.4%) patients with clinical
and surgical stage I or II endometrial adenocarcinoma, and remained so in all patients who …